Changes in lipid-lowering therapy following a cardiovascular event in patients with diabetes

被引：0
|
作者：
Okerson, T. [1 ]
Cohen, S. S. [2 ]
Killian, J. M. [3 ]
Weston, S. A. [3 ]
Monda, K. L. [1 ]
Chamberlain, A. M. [3 ]
机构：
[1] Amgen Inc, Thousand Oaks, CA USA
[2] EpidStat Inst, Ann Arbor, MI USA
[3] Mayo Clin, Rochester, MN USA
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1167
引用
收藏
页码：S537 / S538
页数：2
相关论文
共 50 条
  • [1] Changes in lipid-lowering therapy prescription patterns following a second cardiovascular disease event
    Chamberlain, A.
    Cohen, S.
    Killian, J.
    Weston, S.
    Okerson, T.
    Monda, K.
    EUROPEAN HEART JOURNAL, 2017, 38 : 31 - 31
  • [2] Comparison of Lipid-Lowering Treatment in Patients with Diabetes and/or Cardiovascular Disease
    Cohen, Sarah S.
    Chamberlain, Alanna M.
    Killian, Jill M.
    Monda, Keri L.
    Weston, Susan A.
    Okerson, Ted
    DIABETES, 2017, 66 : LB57 - LB57
  • [3] Combination lipid-lowering therapy in diabetes
    Michael H. Davidson
    Current Diabetes Reports, 2003, 3 (3) : 263 - 268
  • [4] Lipid-lowering therapy in diabetes mellitus
    Niemeijer-Kanters, SDJM
    Banga, JD
    Erkelens, DW
    NETHERLANDS JOURNAL OF MEDICINE, 2001, 58 (05): : 214 - 222
  • [5] LIPID-LOWERING THERAPY AFTER AN ATHEROSCLEROTIC EVENT
    ROBERTS, WC
    AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (10): : 693 - 695
  • [6] Cardiovascular risk and lipid-lowering drug therapy
    Stulnig, T.
    DIABETOLOGE, 2012, 8 (07): : 568 - 572
  • [7] Lipid-Lowering Prescription Patterns in Patients With Diabetes Mellitus or Cardiovascular Disease
    Chamberlain, Alanna M.
    Cohen, Sarah S.
    Killian, Jill M.
    Monda, Ken L.
    Weston, Susan A.
    Okerson, Ted
    AMERICAN JOURNAL OF CARDIOLOGY, 2019, 124 (07): : 995 - 1001
  • [8] Lipids, lipid-lowering therapy and diabetes complications
    Valensi, P.
    Picard, S.
    DIABETES & METABOLISM, 2011, 37 (01) : 15 - 24
  • [9] Lipid-lowering Therapy in Patients With High Cardiovascular Risk: Dose or Combination?
    Roever, Leonardo
    Biondi-Zoccai, Giuseppe
    Rao, Sunil V.
    CLINICAL THERAPEUTICS, 2017, 39 (03) : 659 - 660
  • [10] Benefits of lipid-lowering therapy in patients with type 2 diabetes mellitus
    Betteridge, J
    AMERICAN JOURNAL OF MEDICINE, 2005, 118 : 10S - 15S
12345